טוען...
The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
INTRODUCTION: Upadacitinib is a Janus kinase inhibitor with demonstrated efficacy in patients with rheumatoid arthritis (RA). OBJECTIVE: The aim of this study was to assess the long-term safety of upadacitinib in patients with active RA from Japan compared with global clinical trial populations. MET...
שמור ב:
| הוצא לאור ב: | Drug Saf |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8184701/ https://ncbi.nlm.nih.gov/pubmed/34041702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-021-01067-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|